Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: A population-based cohort study
Liver fibrosis is the strongest predictor of liver-related mortality in many chronic liver diseases. NT-ProBNP is independently associated with cardiovascular mortality in general population settings. Here, we evaluate the relative contribution of non-invasively identified liver fibrosis and NT-ProBNP on all-cause and cardiovascular mortality in patients with metabolic (dysfunction)-associated steatotic liver disease (MASLD).
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Stefano Ciardullo, Rosa Cannistraci, Emanuele Muraca, Francesca Zerbini, Gianluca Perseghin Source Type: research
More News: Cardiology | Cardiovascular | Heart | Liver | Liver Disease | Nutrition | Study | Urology & Nephrology